Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$393M |
| 2 |
Baker Hughes
BKR
|
+$69.8M |
| 3 |
ExxonMobil
XOM
|
+$69.8M |
| 4 |
Apple
AAPL
|
+$63.5M |
| 5 |
Microsoft
MSFT
|
+$55M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAI
Reynolds American Inc
RAI
|
+$250M |
| 2 |
DD
Du Pont De Nemours E I
DD
|
+$229M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$175M |
| 4 |
BHI
Baker Hughes
BHI
|
+$134M |
| 5 |
SPLS
Staples Inc
SPLS
|
+$53.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.85% |
| 2 | Financials | 14.71% |
| 3 | Healthcare | 13.11% |
| 4 | Industrials | 11.16% |
| 5 | Consumer Discretionary | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
IMAX
IMAX
$2.82B
| $2.25M | ﹤0.01% |
99,100
| – | – |
|
2252
Babcock & Wilcox
BW
$1.37B
| $2.23M | ﹤0.01% |
66,956
+21,260
| +47% | +$1.31M |
|
2253
Waterstone Financial
WSBF
$375M
| $2.22M | ﹤0.01% |
114,042
-11,262
| -9% | -$207K |
|
2254
Mercantile Bank Corp
MBWM
$1.06B
| $2.22M | ﹤0.01% |
63,593
+38,293
| +151% | +$1.21M |
|
|
BFX
2255
DELISTED
BowFlex Inc.
BFX
| $2.22M | ﹤0.01% |
131,314
-10,200
| -7% | -$176K |
|
2256
Alto Ingredients
ALTO
$323M
| $2.19M | ﹤0.01% |
394,143
+155,616
| +65% | +$848K |
|
2257
Marcus Corp
MCS
$902M
| $2.19M | ﹤0.01% |
78,884
-3,790
| -5% | -$102K |
|
|
ASRT
2258
DELISTED
Assertio
ASRT
| $2.17M | ﹤0.01% |
6,235
+376
| +6% | +$177K |
|
2259
Laureate Education
LAUR
$5.07B
| $2.16M | ﹤0.01% |
148,631
-18,610
| -11% | -$292K |
|
|
XCRA
2260
DELISTED
Xcerra Corporation
XCRA
| $2.15M | ﹤0.01% |
218,127
+114,535
| +111% | +$1.11M |
|
2261
Pacific Biosciences
PACB
$357M
| $2.15M | ﹤0.01% |
408,638
+132,379
| +48% | +$569K |
|
2262
RadNet
RDNT
$5.92B
| $2.13M | ﹤0.01% |
184,032
+21,000
| +13% | +$192K |
|
|
ROCC
2263
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $2.11M | ﹤0.01% |
52,800
+17,634
| +50% | +$677K |
|
2264
Inovio Pharmaceuticals
INO
$80.5M
| $2.11M | ﹤0.01% |
27,722
-113
| -0.4% | -$8.41K |
|
2265
Mercer International
MERC
$34.5M
| $2.11M | ﹤0.01% |
177,916
+64,880
| +57% | +$727K |
|
2266
Coherus Oncology
CHRS
$185M
| $2.11M | ﹤0.01% |
157,681
-3,685
| -2% | -$48.7K |
|
2267
Village Super Market
VLGEA
$617M
| $2.11M | ﹤0.01% |
85,086
+1,740
| +2% | +$41.8K |
|
|
ITCI
2268
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.1M | ﹤0.01% |
133,183
-1,102
| -0.8% | -$16.2K |
|
2269
Workiva
WK
$3.76B
| $2.1M | ﹤0.01% |
100,693
+18,099
| +22% | +$358K |
|
2270
Trupanion
TRUP
$1.33B
| $2.1M | ﹤0.01% |
79,456
+42,156
| +113% | +$968K |
|
|
ENZ
2271
DELISTED
Enzo Biochem, Inc.
ENZ
| $2.1M | ﹤0.01% |
200,450
+75,169
| +60% | +$834K |
|
2272
Virtu Financial
VIRT
$4.94B
| $2.1M | ﹤0.01% |
129,396
-8,412
| -6% | -$142K |
|
|
GNMK
2273
DELISTED
GenMark Diagnostics, Inc
GNMK
| $2.09M | ﹤0.01% |
216,894
-9,430
| -4% | -$98K |
|
2274
Icon
ICLR
$12.7B
| $2.08M | ﹤0.01% |
18,291
+1,578
| +9% | +$168K |
|
|
TTSH
2275
DELISTED
Tile Shop Holdings
TTSH
| $2.08M | ﹤0.01% |
163,618
-3,817
| -2% | -$59.7K |
|
Similar funds
Charles Schwab's Q3 2017 Portfolio in Review
As of Q3 2017, Charles Schwab held 3,155 positions worth $115B, up 7.6% from $106B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Charles Schwab deployed $3.77B of net new capital in Q3 2017, opening 56 new positions and adding to 2,228 existing holdings. Its largest new stake was Baker Hughes: 1,967,118 shares worth $72M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Stanley Black & Decker, an estimated $45.1M trimmed.
- Charles Schwab's largest Q3 2017 buy was Baker Hughes: 1,967,118 shares worth $72M.
- Charles Schwab added most to DuPont de Nemours in Q3 2017, an estimated $393M increase.
- Charles Schwab's biggest Q3 2017 reduction was Stanley Black & Decker, cutting an estimated $45.1M.
- Charles Schwab fully exited Reynolds American Inc in Q3 2017, selling an estimated $250M.
- Charles Schwab's ten largest holdings make up 14% of its $115B portfolio in Q3 2017.
- Charles Schwab opened 56 new positions and closed 79 in Q3 2017.
- Charles Schwab's portfolio value rose 7.6% quarter-over-quarter to $115B.
Based on Charles Schwab's 13F filing for Q3 2017, filed 13 Nov 2017.